Thursday, Feb 1, 2024 · SEC filings
What the smart money revealed on Feb 1
495 insider filings came in. We hid 31 planned (10b5-1) sellers and 365 people whose filings were routine, like grants and tax withholding.
3 insiders at Columbia Banking System (COLB) bought $214K of stock
Roles: Executive VP, Chief Strategy/Innovation Offc, Director. Several insiders buying in the same few days is rare.
Vera Therapeutics (VERA) Director Maha Katabi bought $5M
161,290 shares on the open market. Not a grant or an option exercise.
QNB (QNBC) Director Randy Bimes bought $1.26M
48,978 shares on the open market. Not a grant or an option exercise.
RBB Bancorp (RBB) Director James Kao bought $562K
32,000 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 4 checked quarters beat the typical stock 6 months later.
Cleveland-Cliffs (CLF) Director Ron Bloom bought $506K
25,000 shares on the open market. Not a grant or an option exercise.
OLIN (OLN) Chairman Scott Sutton sold $31.5M
Not marked as a planned 10b5-1 sale. Sold 100% of the shares they held directly. Still holds 2,083 shares.
Morgan Stanley (MS) Chief Legal/Admin Officer Eric Grossman sold $4.68M
Not marked as a planned 10b5-1 sale. Sold 18% of the shares they held directly. Still holds 234,627 shares.
Guggenheim Strategic Opportunities Fund (GOF) Director Randall Barnes sold $140K
Not marked as a planned 10b5-1 sale. Sold 63% of the shares they held directly. Still holds 5,849 shares.
Show 22 more real buys
Show 43 more real sales
13F season
Holdings as of Dec 31, 2023 are due Feb 14
49 funds have filed so far. 40 filed for the quarter before.
Biggest real insider buys, Jan 26–Feb 1
Open-market buys by officers and directors, filed in the 7 days up to Feb 1.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.